Effects of acute tiagabine administration on aggressive responses of adult male parolees

Journal of Psychopharmacology

Volumn 22, Issue 2, 2008, Pages 144-152

  Lieving, Lori M ^a,b   Cherek, Don R ^a   Lane, Scott D ^a   Tcheremissine, Oleg V ^a   Nouvion, Sylvain O ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Carolinas College of Health Sciences   (United States)

Author keywords

aminobutyric acid; Aggression; Escape; Human; Tiagabine

Indexed keywords

4 AMINOBUTYRIC ACID; PLACEBO; TIAGABINE;

4 AMINOBUTYRIC ACID UPTAKE; ADULT; AGGRESSION; AGGRESSIVENESS; AGITATION; ARTICLE; AVERSIVE BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; ESCAPE BEHAVIOR; HUMAN; MALE; POINT SUBTRACTION AGGRESSION PARADIGM; PRIORITY JOURNAL; PRISON; PROBATION; REINFORCEMENT; SCORING SYSTEM;

ADULT; AGGRESSION; APPETITIVE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCAPE REACTION; GABA AGONISTS; HUMANS; MALE; MOTIVATION; NIPECOTIC ACIDS; PRISONERS;

EID: 40049108160     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107078489     Document Type: Article

References (89)

1. Abbott Laboratories (1997) Tiagabine prescribing information. Bagsvaerd, Denmark.
2. Adkins J.C., Noble S. (1998) Tiagabine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Drugs 55: 437 - 460
3. Afaq I., Riaz J., Sedky K., Chung D J., Vanina Y., elMallkh R., Lippman S. (2002) Divalproex as a calmative adjunct for aggressive schizophrenic patients. J Ky Med Assoc 100: 17 - 22
4. Allen M.H. (2000) Managing the agitated patient: A reappraisal of the evidence. J Clin Psychiatry 61 (Suppl 14). 11 - 20
5. Barratt E.S., Stanford M.S., Felthous A.R., Kent T.A. (1997) The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J Clin Psychpharmacol 17: 341 - 349
6. Ben-Porath D.D., Taylor S.P. (2002) The effects of diazepam (Valium) and aggressive disposition on human aggression: An experimental investigation. Addict Behav 27: 167 - 177
7. Berman M.E., Taylor S.P. (1995) The effects of triazolam on aggression in men. Exp Clin Psychopharmacol 3: 411 - 416
8. Berrettini W.H., Nurnberger J.I. Jr, Hare T.A., Simmons-Alling S., Gershon E.S., Post R.M. (1983) Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol Psychiatry 18: 185 - 194
9. Binder R.L., McNeil D.E. (1999) Contemporary practices in managing acutely vilent patients in 20 psyhicatric emergency rooms. Emerg Psychiatry 50: 1553 - 1554
10. Bond A., Lader M. (1988) Differential effects of oxazepam and lorazepam on aggressive responding. Psychopharmacology (Berl) 95: 369 - 373
11. Borden L A., Murali Dhar T G., Smith K E. et al. (1994) Tiagabine, SK & F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269: 219 - 224
12. Buss A.H., Perry M. (1992) The aggression questionnaire. J Pers Soc Psychol 63: 452 - 459
13. Cherek D.R. (1992) Point subtraction aggression paradigm (PSAP). University of Texas - Houston
14. Cherek D.R., Lane S.D. (1999) Effects of d,l-fenfluramine on aggressive and impulsive responding in adult males with a history of conduct disorder. Psychopharmacology (Berl) 146: 473 - 481
15. Cherek D.R., Lane S.D., Dougherty D.M., Moeller F.G., White S. (2000) Laboratory and questionnaire measures of aggression among female parolees with violent or nonviolent histories. Aggress Beh 26: 291 - 307
16. Cherek D.R., Lane S.D., Pietras C.J., Sharon J., Steinberg J.L. (2002) Acute effects of baclofen, a gamma-aminobutyric acid-B agonist, on laboratory measures of aggressive and escape responses of adult male parolees with and without a history of conduct disorder. Psychopharmacology (Berl) 164: 160 - 167
17. Cherek D.R., Moeller F.G., Schnapp W., Dougherty D.M. (1997) Studies of violent and nonviolent male parolees: I. Laboratory and psychometric measurements of aggression. Biol Psychiatry 41: 514 - 522
18. Cherek D.R., Schnapp W., Moeller F.G., Dougherty D.M. (1996) Laboratory measures of aggressive responding in male parolees with violent and nonviolent histories. Aggress Beh 22: 27 - 36
19. Cherek D.R., Spiga R., Roache J.D., Cowan K.A. (1991) Effects of triazolam on human aggressive, escape and point-maintained responding. Pharmacol Biochem Behav 40: 835 - 839
20. Cherek D.R., Steinberg J.L., Kelly T.H., Robinson D.E., Spiga R. (1990) Effects of acute administration of diazepam and d-amphetamine on aggressive and escape responding of normal male subjects. Psychopharmacology (Berl) 100: 173 - 181
21. Cherek D.R., Tcheremissine O.V., Lane S.D. (2006) Psychopharmacology of Human Aggression: Laboratory and Clinical Studies. In Nelson R J (ed.). Biology of aggression. Oxford Univ Press, New York, pp. 424 - 446
22. Cherek D.R., Tcheremissine O.V., Lane S.D., Pietras C.J. (2004) Acute effects of gabapentin on laboratory measures of aggressive and escape responses of adult parolees with and without a history of conduct disorder. Psychopharmacology (Berl) 171: 405 - 412
23. Clement J., Simsler S., Ciesielski L., Mandel P., Cabib S., Puglisi-Allegra S. (1987) Age-dependent changes of brain GABA levels, turnover rates and shock-induced aggressive behavior in inbred strains of mice. Pharmacol Biochem Behav 26: 83 - 88
24. Cleton A., Altorf B.A., Voskuyl R.A., Danhof M. (2000) Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels. Br J Pharmacol 130: 1037 - 1044
25. Coccaro E.F., Kavoussi R.J., Hauger R.L. (1995) Physiological responses to D-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorders. Int Clin Psychopharmacol 10: 177 - 179
26. Conchillo M.P., Martinez-Sanchis S., Salvador A., Simon V.M. (2002) The GABAergic effect of lw doses of lorazepam on social behavior. Aggress Behav 28: 248 - 256
27. Cutler M.G., Rodgers R.J., Jackson J.E. (1997) Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine, I: social interactions. Pharmacol Biochem Behav 57: 119 - 125
28. DaVanzo J.P., Sydow M. (1979) Inhibitions of isolation-induced aggressive behavior with GABA transaminase inhibitors. Psychopharmacology (Berl) 62: 23 - 27
29. Ferreira A., Picazo O., Uriarte N., Pereira M., Fernandez-Guasti A. (2000) Inhibitory effect of buspirone and diazepam but not of 8-OH-DPAT on maternal behavior and aggression. Pharmacol Biochem Behav 66: 389 - 396
30. Fink-Jensen A., Suzdak P.D., Swedberg M.D., Judge M.E., Hansen L., Nielsen P.G. (1992) The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol 220: 197 - 201
31. First M.B., Spitzer R.L., Gibbon M., Williams J B W (1996) Structured clinical interview for DSM-IV axis I disorders: non patient edition (SCID-NP), 2 nd edition. State Psychiatric Institute, New York
32. Fish E.W., Faccidomo S., DeBold J.F., Miczek K.A. (2001) Alcohol, allpregnanolone and aggression in mice. Psychopharmacology (Berl) 153: 473 - 483
33. Fish E.W., DeBold J.F., Miczek K.A. (2005) Escalated aggression as a reward: corticosterone, and a GABAA receptor positive modulators in mice. Psychopharmacolgy (Berl) 182: 116 - 127
34. Frankenburg F.R., Zanarini M.C. (2002) Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry 63: 442 - 446
35. Friedel R.O. (2004) Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacology 29: 1029 - 1039
36. Gedye A. (1992) Serotonin-GABA treatment is hypothesized for self-injury in Lesch-Nyhan syndrome. Medical Hypotheses 38: 325 - 328
37. Gonzalez G., Sevarino K., Sofuoglu M., Poling J., Oliveto A., Gonsai K., George T.P., Kosten T.R. (2003) Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98: 1625 - 1632
38. Gourley S.L., DeBold J.F., Yin W., Miczek K.A. (2005) Benzodiazepines and heightened aggressive behavior in rats: reduction by GABAA/α1 receptor antagonists. Psychopharmacology (Berl) 178: 232 - 240
39. Gregg T.R., Siegel A. (2001) Brain structures and neurotransmitters regulating aggression in cats: implications for human aggression. Prog Neuropsychopharmacol Biol Psychiatry 25: 91 - 140
40. Griffith J.L. (1985) Treatment of episodic behavioral disorders with rapidly absorbed benzodiazepines. J Nerv Ment Dis 173: 312 - 315
41. Guillot P.V., Chapouthier G. (1998) Intermale aggression, GAD activity in the olfactory bulbs and Y chromosome effect in seven inbred mouse strains. Behav Brain Res 90: 203 - 206
42. Haug M., Ouss-schlegel M.L., Spetz J.F., Benton D., Brain P.F., Mandel P., Ciesielski L., Simsler S. (1987) An attempt to correlate attack on lactating females and brain GABA levels in C57 and C3H strains and their reciprocal hybrids. Biog Amines 4: 83 - 94
43. Hoffman D.A. (2005) Tiagabine for rage, aggression, and anxiety. J Neuropsychiatry Clin Neurosci 17: 252
44. Hughes D.H. (1999) Acute psychopharmacological management of the aggressive psychotic patient. Psychiatr Serv 50: 1135 - 1137
45. Kaufman K.R., Kugler S.L., Sachdeo R.C. (2002) Tiagabine in the management of postencephalitic epilepsy and impulse control disorder. Epilepsy Behav 3: 190 - 194
46. Kim E. (2002). The use of newer anticonvulsants in neuropsychiatric disorders. Current Psychiatry Reports 4: 331 - 337
47. Lavine R. (1997) Psychopharmacological treatment of aggression and violence in the substance abusing population. J Psychoactive Drugs 29: 321 - 329
48. Lile J.A., Stoops W.W., Glaser P.E., Hays L.R., Rush C.R. (2004) Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug Alcohol Depend 76: 81 - 91
49. Loscher W., Schmidt D. (1987) Diazepam increased gamma aminobutyric acid in human cerebrospinal fluid. J Neurochem 49: 152 - 157
50. Low A.R., Brandes M. (1999) Gabapentin for the management of agitation. J Clin Psychopharmacol 19: 482 - 483
51. Mandel P., Ciesielski L., Maitre M., Simler S., Kempf E., Mack G. (1981) Inhibitory amino acids, aggressiveness, and convulsions. Adv Biochem Psychopharmacol 29: 1 - 9
52. Mathew V.M., Dursun S.M., Reveley M.A. (2000) Increased aggressive, violent, and impulsive behavior in patients during chronic-prolonged benzodiazepine use. Can J Psychiatry 45: 89 - 90
53. Meldrum B.S., Chapman A.G. (1999) Basic mechanisms of gabitril (tiagabine) and future potential developments. Epilepsia 40 (Suppl 9). S2 - S6
54. Michael J. (1993) Establishing operations. Behav Analyst 16: 191 - 206
55. Miczek K A., DeBold J F., vanErp A M., Tornatzy W. (1997) Alcohol, GABA A-benzodiazepine receptor complex, and aggression. Recent Dev Alcohol 13: 139 - 171
56. Miczek K.A., Fish E.W., DeBold J.F. (2003) Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm Behav 44: 242 - 257
57. Miczek K.A., Fish E.W. (2005) Monoamines, GABA, glutamate, and aggression. In Nelson R J (ed.). Biology of aggression. Oxford Univ Press, New York, pp. 114 - 149
58. Miller L.J. (2001) Gabapentin for treatment of behavioral and psychological symptoms of dementia. Ann Pharmacother 35: 427 - 431
59. Nguyen S.A., Deleon C.P., Malcolm R.J., Middaugh L.D. (2005) Tiagabine reduces ethanol reward in C57BL/6 mice under acute and chronic administration regimens. Synapse 56: 135 - 146
60. Nielsen E.B., Suzda P.D., Andersen K.E., Knutsen L J S, Sonnewald U., Braestrup C. (1991) Characterization of tiagabine (NO-328) a new potent and selective GABA uptake inhibitor. Eur J Pharmacol 196: 257 - 266
61. Pabis D.J., Stanislav S.W. (1996) Pharmacotherapy of aggressive behavior. Ann Pharmacother 30: 278 - 287
62. Paredes R.G., Agmo A. (1992) GABA and behavior: the role of receptor subtypes. Neurosci Biobehav Rev 16: 145 - 170
63. Pietras C.J., Lieving L.M., Cherek D.R., Lane S.D., Tcheremissine O.V., Nouvion S. (2005) Acute effects of lorazepam on laboratory measures of aggressive and escape responses of adult male parolees. Behav Pharmacol 16: 243 - 251
64. Podhorna J., Krsiak M. (2000) Behavioural effects of a benzodiazepine receptor partial agonist Ro 19-8022 in the social conflict test in mice. Behav Pharmacol 11: 143 - 151
65. Primrose D.A. (1979) Treatment of self-injurious behavior with a GABA analogue. J Ment Deficiency Res 23: 163 - 173
66. Puglisi-Allegra S., Simler S., Kempf E., Mandel P. (1981) Involvement of the GABAergic system in shock-induced aggressive behavior in two strains of mice. Pharmacol Biochem Behav 14 (Suppl 1). 13 - 18
67. Rosenbaum J.F., Woods S.W., Groves J.E., Klerman G.L. (1984) Emergence of hostility during alprazolam treatment. Am J Psychiatry 141: 792 - 793
68. Salzman C. (1988) Use of benzodiazepines to control disruptive behavior in inpatients. J Clin Psychiatry 49 (Suppl 1). 13 - 15
69. Salzman C., Solomon D., Miyawaki E., Glassman R., Rood L., Flowers E. et al. (1991) Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry 52: 177 - 180
70. Schmitt U., Hiemke C. (1999) Effects of GABA-transporter (GAT) inhibitors on rat behavior in open-field and elevated plus-maze. Behav Pharmacol 10: 131 - 137
71. Schwartz T.L., Nihalani N. (2006) Tiagabine in anxiety disorders. Expert Opin Pharmacother 7: 1977 - 1987
72. Shipley B.B. (1967) The Shipley institute of living scale. Western Psychological Services, Los Angeles, CA
73. Siegel A., Roeling T.A., Gregg T.R., Kruk M.R. (1999) Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev 23: 359 - 389
74. Simler S., Puglisi-Allegra S., Mandel P. (1983) Effects of n-di-propylacetate on aggressive behavior and brain GABA levels in isolated mice. Pharmacol Biochem Behav 18: 717 - 720
75. Sival R.C., Haffmans P.M., Jansen P.A., Duursma S.A., Eikelenboom P. (2002) Sodium valproate in the treatment of aggressive behavior inpatients with dementia- a randomized placebo controlled clinical trial. Int J Geriatr Psychiatry 17: 579 - 585
76. Skinner B.F. (1953) Science and human behavior. The Free Press, New York
77. Sofuoglu M., Mouratidis M., Yoo S., Culligan K., Kosten T. (2005) Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berl) 28: 1 - 7
78. Stanford M.S., Houston R.J., Mathias C.W., Greve K.W., Villemarette-Pittmen N.R., Adams D. (2001) A double-blind placebo-controlled crossover study of phenytoin in individuals with impulse aggression. Psychiatry Res 103: 193 - 203
79. Suzdak P.D., Jansen J.A. (1995) A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36: 612 - 626
80. Taylor S.P. (1967) Aggressive behavior and physiological arousal as a function of provocation and the tendency to inhibit aggression. J Pers 35: 297 - 310
81. Tcheremissine O.V., Lane S.D., Lieving L.M., Rhoades H.M., Nouvion S., Cherek D.R. (2005) Individual differences in aggressive responding to intravenous flumazenil administration in adult male parolees. J Psychopharmacol 19: 640 - 647
82. Uthman B.M., Rowan A.J., Ahmann P.A., Leppik I.E., Schachter S.C., Sommerville K.W., Shu V. (1998) Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol 55: 56 - 62
83. Valzelli L. (1984) Reflections on experimental and human pathology of aggression. Prog Neuropsychopharmacol Biol Psychiatry 8: 311 - 325
84. Weerts E.M., Miczek K.A. (1996) Primate vocalizations during social separation and aggression: effects of alcohol and benzodiazepines. Psychopharmacology (Berl) 127: 255 - 264
85. Wilcox R.E., Gonzalez R.A. (1995) Introduction to neurotransmitters, receptors, signal transduction and second messengers. In Schatzberg A E, Nemeroff C N (eds). Textbook of psychopharmacology. American Psychiatric Press, Washington DC, pp. 3 - 29
86. Wilkinson C.J. (1985) Effects of diazepam (Valium) and trait anxiety on human physical aggression and emotional state. J Behav Med 8: 101 - 114
87. Winer B.J. (1971) Statistical principles in experimental design, 2 nd edn. McGraw-Hill, New York
88. Yudofksy S.C., Silver J.M., Hales R.E. (1995) Treatment of aggressive disorders. In Schatzberg A E, Nemeroff C N (eds). Textbook of psychopharmacology. American Psychiatric Press, Washington DC, pp. 735 - 751
89. Zachary R.A., Crumpton E., Spiegel D.E. (1985) Estimating WAIS-R IQ from the Shipley institute of living scale. J Clin Psychol 41: 532 - 540